Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GL0K
|
|||
| Former ID |
DIB012208
|
|||
| Drug Name |
MRZ-8456
|
|||
| Indication | Movement disorder [ICD-11: 8A07-8A0Z; ICD-10: G20-G26] | Phase 1 | [1] | |
| Company |
Merz & Co GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Positive results of the phase I study for treatment of late complications in Parkinson's Disease. Merz Pharmaceuticals GmbH und Co. KGaA. 2011-04-01. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.